Back to search

University of Birmingham

Development of raman spectroscopic point of care diagnostics for the detection of key targets of disease

Abstract

dc:description.abstract

Inflammatory bowel disease (IBD) and cardiovascular disease (CVD) represent two distinct yet urgent healthcare concerns. IBD, characterised by chronic inflammation of the gastrointestinal tract, poses a significant burden on the affected individuals. Both conditions require early and accurate diagnostic methods to optimise patient care and treatment outcomes. Conversely, CVD continues to be a leading global cause of morbidity and mortality, necessitating innovative approaches to diagnosis and monitoring. Here, we explore the transformative potential of Raman spectroscopy (RS) as a rapid and non-invasive diagnostic tool in the assessment of saliva and blood plasma. The multidimensional approach combining RS with multivariate analysis unveils distinct molecular profiles thus enabling early and accurate disease diagnosis. Classification accuracies of >88 % are demonstrated between three sample types applied to healthy, CVD and follow-up blood plasma. Similarly, in IBD, classification yields accuracies >90 % over four sample types applied to saliva and tissue. This further extends into biomarker discovery, unveiling novel CVD- and IBD-indicative molecular signatures. Feature extraction, inherently connected to classification results, indicates an increase in circulating cytokines, a hallmark of inflammation in both CVD and IBD. Extracellular vesicles (EVs), as biomarkers serve as key carriers of disease-specific biomolecules, therefore, rendering them invaluable in diagnostics and personalised treatment. Conventional EV isolation methods suffer from several limitations such as, low throughput, sample loss, limited scalability and EV damage thus this has led to the exploration of alternative EV isolation techniques. The developed methodologies harness the power of RS to redefine the paradigm of disease diagnosis and risk stratification and as a means of increasing diagnostic accuracy, bridging the translational gap, and facilitating the clinical integration of RS-based diagnostics via a novel lab-on-a-chip (LoC) platform for the isolation and separation of disease-indicative EVs from biofluids. The developed platform marks a significant advance in utilising the diagnostic potential of EVs, offering a streamlined and efficient approach to their isolation and analysis.

Degree

thesis:*
Name dc:type.qualificationname
d_ph
Level dc:type.qualificationlevel
d_ph
Grantor dc:publisher.institution
University of Birmingham
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Buchan, Emma L

Subjects

dc:subject × 3

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
University of Birmingham
Base URL
etheses.bham.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Buchan, Emma L. Development of raman spectroscopic point of care diagnostics for the detection of key targets of disease. d_ph thesis, University of Birmingham, 2024.